Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, driving development of life-saving drugs despite small patient populations. Here’s how it works, who benefits, and why it’s changing.
Read More
